Wedge Capital Management L L P NC Buys 3,150 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wedge Capital Management L L P NC increased its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,547 shares of the company’s stock after acquiring an additional 3,150 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Prestige Consumer Healthcare were worth $6,278,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of PBH. Provence Wealth Management Group bought a new stake in Prestige Consumer Healthcare in the 3rd quarter valued at $26,000. Pacer Advisors Inc. grew its holdings in shares of Prestige Consumer Healthcare by 85.7% in the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after purchasing an additional 204 shares during the last quarter. ORG Partners LLC bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth about $36,000. International Assets Investment Management LLC grew its holdings in Prestige Consumer Healthcare by 1,900.0% during the 4th quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock worth $60,000 after acquiring an additional 931 shares during the last quarter. Finally, Global Retirement Partners LLC grew its holdings in Prestige Consumer Healthcare by 22.6% during the 3rd quarter. Global Retirement Partners LLC now owns 1,364 shares of the company’s stock worth $78,000 after acquiring an additional 251 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 2.0 %

Shares of NYSE PBH opened at $71.23 on Wednesday. The firm has a market capitalization of $3.54 billion, a PE ratio of -43.43, a price-to-earnings-growth ratio of 1.89 and a beta of 0.52. The firm’s 50-day moving average is $70.83 and its 200-day moving average is $64.03. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. Prestige Consumer Healthcare Inc. has a 1 year low of $55.96 and a 1 year high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02. The business had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. Prestige Consumer Healthcare’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the company posted $1.04 EPS. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current year.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of research analyst reports. TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. One equities research analyst has rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.00.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total transaction of $368,184.00. Following the sale, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.